We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
4 Top Stocks to Invest In for Astounding Earnings Growth
Earnings growth is the highest priority for any start-up or a renowned company. This is because a company won't last long if it doesn’t make money.
So, what is earnings growth? Study a company’s revenues over a given period, subtract the production cost, and you have earnings. By the way, this is also considered the most important variable influencing share price. But, expectations of earnings play a noteworthy role.
Earnings Estimates & Share Price Movements
Frequently, we have seen a decline in the stock price despite earnings growth and a rally in price following an earnings decline. This is largely the result of a company’s earnings failing to meet market expectations.
Earnings estimates embody analysts’ opinions on factors such as sales growth, product demand, competitive industry environment, profit margins, and cost control. Thus, earnings estimates serve as a valuable tool, while making investment decisions. Earnings estimates also help analysts assess the cash flow to determine the fair value of a firm.
Thus, investors should look for stocks ready to make a big move. Hence, investors need to buy stocks with historical earnings growth and are seeing a rise in quarterly and annual earnings estimates.
The above criteria narrowed the universe of around 7,839 stocks to only 21. Here are the top four stocks that stand out:
BellRing Brands manufactures and sells nutrition products. The company has a Zacks Rank #1 (Strong Buy). BRBR’s expected earnings growth rate for the current year is 34.9%. You can see the complete list of today’s Zacks #1 Rank stocks here.
ResMed holds a major position worldwide as a designer, manufacturer and distributor of generators, masks and related accessories. The company has a Zacks Rank #1. RMD’s expected earnings growth rate for the current year is 17.9%.
NVIDIA is the worldwide leader in visual computing technologies and the inventor of the graphic processing unit, or GPU. The company has a Zacks Rank #2 (Buy). NVDA’s expected earnings growth rate for the current year is 84.7%.
Transdigm Group is a leading global designer, producer and supplier of highly engineered aerospace components used in commercial and military aircraft. The company has a Zacks Rank #2. TDG’s expected earnings growth rate for the current year is 21.7%.
You can sign up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks.com featured highlights BellRing Brands, ResMed, NVIDIA and Transdigm
For Immediate Release
Chicago, IL – May 15, 2024 – Stocks in this week’s article are BellRing Brands (BRBR - Free Report) , ResMed (RMD - Free Report) , NVIDIA (NVDA - Free Report) and Transdigm Group (TDG - Free Report) .
4 Top Stocks to Invest In for Astounding Earnings Growth
Earnings growth is the highest priority for any start-up or a renowned company. This is because a company won't last long if it doesn’t make money.
So, what is earnings growth? Study a company’s revenues over a given period, subtract the production cost, and you have earnings. By the way, this is also considered the most important variable influencing share price. But, expectations of earnings play a noteworthy role.
Earnings Estimates & Share Price Movements
Frequently, we have seen a decline in the stock price despite earnings growth and a rally in price following an earnings decline. This is largely the result of a company’s earnings failing to meet market expectations.
Earnings estimates embody analysts’ opinions on factors such as sales growth, product demand, competitive industry environment, profit margins, and cost control. Thus, earnings estimates serve as a valuable tool, while making investment decisions. Earnings estimates also help analysts assess the cash flow to determine the fair value of a firm.
Thus, investors should look for stocks ready to make a big move. Hence, investors need to buy stocks with historical earnings growth and are seeing a rise in quarterly and annual earnings estimates.
The above criteria narrowed the universe of around 7,839 stocks to only 21. Here are the top four stocks that stand out:
BellRing Brands manufactures and sells nutrition products. The company has a Zacks Rank #1 (Strong Buy). BRBR’s expected earnings growth rate for the current year is 34.9%. You can see the complete list of today’s Zacks #1 Rank stocks here.
ResMed holds a major position worldwide as a designer, manufacturer and distributor of generators, masks and related accessories. The company has a Zacks Rank #1. RMD’s expected earnings growth rate for the current year is 17.9%.
NVIDIA is the worldwide leader in visual computing technologies and the inventor of the graphic processing unit, or GPU. The company has a Zacks Rank #2 (Buy). NVDA’s expected earnings growth rate for the current year is 84.7%.
Transdigm Group is a leading global designer, producer and supplier of highly engineered aerospace components used in commercial and military aircraft. The company has a Zacks Rank #2. TDG’s expected earnings growth rate for the current year is 21.7%.
You can sign up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2273268/4-top-stocks-to-invest-in-for-astounding-earnings-growth
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.